FDA approves Precedex for sedation in children during procedures.

The FDA has approved Precedex (dexmedetomidine) for sedation of children aged 1 month to less than 18 years during non-invasive procedures like scans or minor exams. Precedex is already used in adults for sedation in the ICU and during procedures. This new approval expands its use to younger patients. The drug works by calming the brain without causing significant breathing problems, which is a key benefit for children. The approval is based on studies showing it is safe and effective for this age group. However, dosing is different for younger children (1 month to under 2 years) compared to older children (2 to under 18 years). Doctors will give a loading dose followed by a maintenance infusion. This approval gives healthcare providers another tool to help children stay calm and comfortable during medical procedures. It does not mean that every child needs this drug. Your child's doctor will decide if Precedex is right based on their health and the procedure. Always talk to your child's doctor about the risks and benefits of any sedation medicine.